Search Results - "Rothmann, Mark" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

by HERNDON, Thomas M, DEISSEROTH, Albert, PALMBY, Todd R, JEE, Josephine, ADAMS, William, MAHAYNI, Houda, BROWN, Janice, DORANTES, Angelica, SRIDHARA, Rajeshwari, FARRELL, Ann T, PAZDUR, Richard, KAMINSKAS, Edvardas, KANE, Robert C, KOTI, Kallappa M, ROTHMANN, Mark D, HABTEMARIAM, Bahru, BULLOCK, Julie, BRAY, Jeffrey D, HAWES, Jessica
Published in Clinical cancer research (01.09.2013)

Get full text

Journal Article

Finding the (biomarker-defined) subgroup of patients who benefit from a novel therapy: No time for a game of hide and seek

Finding the (biomarker-defined) subgroup of patients who benefit from a novel therapy: No time for a game of hide and seek

by McShane, Lisa Meier, Rothmann, Mark D, Fleming, Thomas R
Published in Clinical trials (London, England) (01.08.2023)

Get more information

Journal Article

Issues in Using Progression-Free Survival When Evaluating Oncology Products

Issues in Using Progression-Free Survival When Evaluating Oncology Products

by FLEMING, Thomas R, ROTHMANN, Mark D, LU, Hong Laura
Published in Journal of clinical oncology (10.06.2009)

Get full text

Journal Article

U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma

U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma

by DE CLARO, R. Angelo, MCGINN, Karen, ROTHMANN, Mark, SHAPIRO, Marjorie, BORREGO, Francisco, CLOUSE, Kathleen, XIAO HONG CHEN, BROWN, Janice, AKINSANYA, Lara, KANE, Robert, KAMINSKAS, Edvardas, FARRELL, Ann, KWITKOWSKI, Virginia, PAZDUR, Richard, BULLOCK, Julie, KHANDELWAL, Aakanksha, HABTEMARIAM, Bahru, OUYANG, Yanli, SABER, Haleh, LEE, Kyung, KOTI, Kallappa
Published in Clinical cancer research (01.11.2012)

Get full text

Journal Article

U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with Intermediate and High-Risk Myelofibrosis

U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with Intermediate and High-Risk Myelofibrosis

by DEISSEROTH, Albert, KAMINSKAS, Edvardas, BULLOCK, Julie, BURKE, Laurie B, RAHMAN, Atiqur, SRIDHARA, Rajeshwari, FARRELL, Ann, PAZDUR, Richard, GRILLO, Joseph, WEI CHEN, SABER, Haleh, LU, Hong L, ROTHMANN, Mark D, BRAR, Satjit, JIAN WANG, GARNETT, Christine
Published in Clinical cancer research (15.06.2012)

Get full text

Journal Article

U.S. Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate as Treatment for Chronic Myeloid Leukemia

U.S. Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate as Treatment for Chronic Myeloid Leukemia

by Alvandi, Firoozeh, Kwitkowski, Virginia E., Ko, Chia‐Wen, Rothmann, Mark D., Ricci, Stacey, Saber, Haleh, Ghosh, Debasis, Brown, Janice, Pfeiler, Erika, Chikhale, Elsbeth, Grillo, Joseph, Bullock, Julie, Kane, Robert, Kaminskas, Edvardas, Farrell, Ann T., Pazdur, Richard
Published in The oncologist (Dayton, Ohio) (01.01.2014)

Get full text

Journal Article

$U.S. Food and Drug Administration Approval: Ofatumumab for the Treatment of Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine and Alemtuzumab$

U.S. Food and Drug Administration Approval: Ofatumumab for the Treatment of Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine and Alemtuzumab

by LEMERY, Steven J, ZHANG, Jenny, KEEGAN, Patricia, PAZDUR, Richard, ROTHMANN, Mark D, JUN YANG, EARP, Justin, HONG ZHAO, MCDOUGAL, Andrew, PILARO, Anne, CHIANG, Raymond, GOOTENBERG, Joseph E
Published in Clinical cancer research (01.09.2010)

Get full text

Journal Article

Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation

Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation

by Fleming, Thomas R., Garnett, Christine E., Conklin, Laurie S., Corriol-Rohou, Solange, Hariharan, Sudharshan, Hsu, Daphne, Mueller-Velten, Guenther, Mulugeta, Yeruk, Portman, Ronald, Rothmann, Mark D., Stockbridge, Norman L., Wandel, Simon, Zhang, Jialu, Yao, Lynne
Published in Therapeutic innovation & regulatory science (01.01.2023)

Get full text

Journal Article

Some essential considerations in the design and conduct of non-inferiority trials

Some essential considerations in the design and conduct of non-inferiority trials

by Fleming, Thomas R, Odem-Davis, Katherine, Rothmann, Mark D, Li Shen, Yuan
Published in Clinical trials (London, England) (01.08.2011)

Get full text

Journal Article

Approval Summary for Imatinib Mesylate Capsules in the Treatment of Chronic Myelogenous Leukemia

Approval Summary for Imatinib Mesylate Capsules in the Treatment of Chronic Myelogenous Leukemia

by COHEN, Martin H, WILLIAMS, Grant, ROTHMANN, Mark, GANG CHEN, KHIN MAUNG U, STATEN, Ann M, PAZDUR, Richard, JOHNSON, John R, DUAN, John, GOBBURU, Jogarao, RAHMAN, Atiqur, BENSON, Kimberly, LEIGHTON, John, KIM, Sung K, WOOD, Rebecca
Published in Clinical cancer research (01.05.2002)

Get full text

Journal Article

U.S. Food and Drug Administration Approval: Panitumumab for Epidermal Growth Factor Receptor–Expressing Metastatic Colorectal Carcinoma with Progression Following Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Containing Chemotherapy Regimens

U.S. Food and Drug Administration Approval: Panitumumab for Epidermal Growth Factor Receptor–Expressing Metastatic Colorectal Carcinoma with Progression Following Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Containing Chemotherapy Regimens

by GIUSTI, Ruthann M, SHASTRI, Kaushikkumar, KEEGAN, Patricia, WEISS, Karen D, PAZDUR, Richard, PILARO, Anne M, FUCHS, Chana, CORDOBA-RODRIGUEZ, Ruth, KOTI, Kallappa, ROTHMANN, Mark, MEN, Angela Yuxin, HONG ZHAO, HUGHES, Monica
Published in Clinical cancer research (01.03.2008)

Get full text

Journal Article

Design and analysis of non-inferiority mortality trials in oncology

Design and analysis of non-inferiority mortality trials in oncology

by Rothmann, Mark, Li, Ning, Chen, Gang, Chi, George Y. H., Temple, Robert, Tsou, Hsiao-Hui
Published in Statistics in medicine (30.01.2003)

Get full text

Journal Article

Inferences on a life distribution by sampling from the ages or the ages at death

Inferences on a life distribution by sampling from the ages or the ages at death

by Rothmann, Mark D
Published in Lifetime data analysis (01.09.2006)

Get full text

Journal Article

Perspectives on informative Bayesian methods in pediatrics

Perspectives on informative Bayesian methods in pediatrics

by Travis, James, Rothmann, Mark, Thomson, Andrew
Published in Journal of biopharmaceutical statistics (02.11.2023)

Get full text

Journal Article

Missing Data in Biologic Oncology Products

Missing Data in Biologic Oncology Products

by Rothmann, Mark D., Koti, Kallappa, Lee, Kyung Yul, Lu, Hong Laura, Shen, Yuan Li
Published in Journal of biopharmaceutical statistics (01.11.2009)

Get full text

Journal Article

14th Annual University of Pennsylvania Conference on statistical issues in clinical trials/subgroup analysis in clinical trials: Opportunities and challenges (afternoon panel discussion)

14th Annual University of Pennsylvania Conference on statistical issues in clinical trials/subgroup analysis in clinical trials: Opportunities and challenges (afternoon panel discussion)

by Imai, Kosuke, Rosenblum, Michael, Rothmann, Mark
Published in Clinical trials (London, England) (01.08.2023)

Get more information

Journal Article

On Non-inferiority Analysis Based On Delta-method Confidence Intervals

On Non-inferiority Analysis Based On Delta-method Confidence Intervals

by Rothmann, Mark D., Tsou, Hsiao-Hui
Published in Journal of biopharmaceutical statistics (01.08.2003)

Get full text

Journal Article

Testing in a Prespecified Subgroup and the Intent-to-Treat Population

Testing in a Prespecified Subgroup and the Intent-to-Treat Population

by Rothmann, Mark D., Zhang, Jenny J., Lu, Laura, Fleming, Thomas R.
Published in Drug information journal (01.03.2012)

Get full text

Journal Article

Resampling‐based stepwise multiple testing procedures with applications to clinical trial data

Resampling‐based stepwise multiple testing procedures with applications to clinical trial data

by He, Jiwei, Li, Feng, Gao, Yan, Rothmann, Mark
Published in Pharmaceutical statistics : the journal of the pharmaceutical industry (01.03.2021)

Get full text

Journal Article

Bayesian Hierarchical Models for Subgroup Analysis

Bayesian Hierarchical Models for Subgroup Analysis

by Wang, Yun, Tu, Wenda, Koh, William, Travis, James, Abugov, Robert, Hamilton, Kiya, Zheng, Mengjie, Crackel, Roberto, Bonangelino, Pablo, Rothmann, Mark
Published in Pharmaceutical statistics : the journal of the pharmaceutical industry (15.07.2024)

Get full text

Journal Article